Summary
Classical genetic studies document strong complex genetic contributions to abuse of multiple addictive substances. to mnemonic processes that are likely to include those involved in substance dependence, and to the volumes of brain gray matter in regions that are likely to contribute to mnemonic/ cognitive and to addictive processes. The working idea that these three heritable phenotypes are likely to share some of the same complex genetic underpinnings is presented. This review contains association-based molecular genetic studies of addiction that largely derive from my laboratory and their fit with linkage data from other laboratories. These combined results now identify many of the loci and genes that contain allelic variants that are likely to provide the heritable components of human addiction vulnerability. These data are also likely to have broad implications for neurotherapeutics. Drugs with potential abuse liabilities are widely used for indications that include pain, anxiety, sleep, seizure, and attentional disorders. There is increasing nonmedical use of these prescribed substances. Increasing information about addiction vulnerability gene variants should help to improve management of risks of dependence in individuals who receive such therapeutics. In addition, since mnemonic components that correlate well with individual differences in brain regional volumes are likely to play major roles in addiction processes, many addiction vulnerability genes are also good candidates to contribute to individual differences in mnemonic processes. Recently elucidation of addiction-associated haplotypes for the “cell adhesion” Nr-CAM gene illustrate several of these points.
Article PDF
Similar content being viewed by others
References
Uhl GR. Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process.Neuropharmacology 47 [Suppl 1]: 140–147, 2004.
Berke JD, Hyman SE. Addiction, dopamine, and the molecular mechanisms of memory.Neuron 25: 515–532, 2000.
Nestler EJ. Common molecular and cellular substrates of addiction and memory.Neurobiol Learn Mem 78: 637–647, 2002.
Smith MY, Woody G. Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: patterns, user characteristics, and management options.Curr Psychiatry Rep 7: 337–343, 2005.
Uhl GR, Elmer G, Pickens R. Genetic influences in drug abuse. In: Psychopharmacology: the fourth generation. (Bloom FE, Kupfer DJ, eds), pp 1793–1806. New York: Raven Press, 1995.
Uhl GR, Liu QR, Naiman D. Substance abuse vulnerability loci: converging genome scanning data.Trends Genet 18: 420–425, 2002.
Uhl GR. Molecular genetics of substance abuse vulnerability: a current approach.Neuropsychopharmacology 20: 3–9, 1999.
Kendler KS, Karkowski LM, Corey LA, Prescott CA, Neale MC. Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women.Br J Psychiatry 175: 351–356, 1999.
Kendler KS, Prescott CA. Cocaine use, abuse and dependence in a population-based sample of female twins.Br J Psychiatry 173: 345–350, 1999.
Kendler KS, Prescott CA, Neale MC, Pedersen NL. Temperance board registration for alcohol abuse in a national sample of Swedish male twins, bom 1902 to 1949.Arch Gen Psychiatry 54: 178–184, 1997.
Kendler KS, Thornton LM, Pedersen NL. Tobacco consumption in Swedish twins reared apart and reared together.Arch Gen Psychiatry 57: 886–892, 2000.
Pickens RW, Svikis DS, McGue M, Lykken DT, Heston LL, Clayton PJ. Heterogeneity in the inheritance of alcoholism: a study of male and female twins.Arch Gen Psychiatry 48: 19–28, 1991.
True WR, Heath AC, Scherrer JF, Xian H, Lin N, Eisen SA et al. Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms.Am J Med Genet 88: 391–397, 1999.
True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC et al. Common genetic vulnerability for nicotine and alcohol dependence in men.Arch Gen Psychiatry 56: 655–661, 1999.
Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs.Am J Med Genet 67: 473–477, 1996.
Tsuang MT, Lyons MJ, Harley RM, Xian H, Eisen S, Goldberg J et al. Genetic and environmental influences on transitions in drug use.Behav Genet 29: 473–479, 1997.
Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.Arch Gen Psychiatry 55: 967–972, 1998.
Wright M, De Geus E, Ando J, Luciano M, Posthuma D, Ono Y, et al. Genetics of cognition: outline of a collaborative twin study.Twin Res 4: 48–56, 2001.
Geschwind DH, Miller BL, DeCarli C, Carmelli D. Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness.Proc Natl Acad Sci USA 99: 3176–3181, 2002.
Sullivan EV, Pfefferbaum A, Swan GE, Carmelli D. Heritability of hippocampal size in elderly twin men: equivalent influence from genes and environment.Hippocampus 11: 754–762, 2001.
Posthuma D, Baare WF, Hulshoff Pol HE, Kahn RS, Boomsma DI, De Geus EJ. Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed.Twin Res 6: 131–139, 2003.
Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, Moore E, et al. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population.Am J Med Genet 81: 216–221, 1998.
Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P et al. Genome-wide search for genes affecting the risk for alcohol dependence.Am J Med Genet 81: 207–215, 1998.
Stallings MC, Corley RP, Hewitt JK, Krauter KS, Lessem JM, Mikulich SK et al. A genome-wide search for QTLs influencing substance dependence vulnerabity in adolescence.Drug Alcohol Depend 70: 295–307, 2003.
Straub RE, Sullivan PF, Ma Y, Myakishev MV, Harris-Kerr C, Wormley B et al. Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study.Mol Psychiatry 4: 129–144, 1999.
Foroud T, Edenberg HJ, Goate A, Rice J, Flury L, Koller DL et al. Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping.Alcohol Clin Exp Res 24: 933–945, 2000.
Gelernter J, Panhuysen C, Weiss R, Brady K, Hesselbrock V, Rounsaville B et al. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia.Am J Med Genet 136: 45–52, 2005.
Gelernter J, Liu X, Hesselbrock V, Page GP, Goddard A, Zhang H. Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking.Am J Med Genet 128: 94–101, 2004.
Wang D, Ma JZ, Li MD. Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis.Pharmacogenomics J 5: 166–172, 2005.
Ma JZ, Zhang D, Dupont RT, Dockter M, Elston RC, Li MD. Mapping susceptibility loci for alcohol consumption using number of grams of alcohol consumed per day as a phenotype measure.BMC Genet 31 [Suppl l]: S104, 2003.
Li MD, Ma JZ, Cheng R, Dupont RT, Williams NJ, Crews KM,. et al. Framingham Heart Study: a genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population.BMC Genet 31 [Suppl l]: S103, 2003.
Bergen AW, Yang XR, Bai Y, Beerman MB, Goldstein AM, Goldin LR. Framingham Heart Study: genomic regions linked to alcohol consumption in the Framingham Heart Study.BMC Genet 31 [Suppl l]: S101, 2003.
Uhl GR. Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results.Ann NY Acad Sci 1025: 1–13, 2004.
Uhl GR, Liu QR, Walther D, Hess J, Naiman D. Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.Am J Hum Genet 69: 1290–1300, 2001.
Liu QR, Drgon T, Walther D, Johnson C, Poleskaya O, Hess J et al. Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples.Proc Natl Acad Sci USA 102: 11864–11869, 2005.
Johnson C, Drgon T, Liu Q-R, Walther D, Edenberg H, Rice J, Foroud T, Uhl GR. Pooled association genome scanning for alcohol dependence using 104,268 SNPS: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the Collaborative Study on the Genetics of Alcoholism. American J Med Genetics (Part B) (in press).
Dean C, Dresbach T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function.Trends Neurosci 29: 21–29, 2006.
Ishiguro H, Liu QR, Gong JP, Hall FS, Ujike H, Morales M et al. NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression and altered drug reward in knockout mice.Neuropsychopharmacology 31: 572–584, 2006.
Sakurai T, Lustig M, Babiarz J, Furley AJ, Tait S, Brophy PJ et al. Overlapping functions of the cell adhesion molecules Nr-CAM and LI in cerebellar granule cell development.J Cell Biol 154: 1259–1273, 2001.
Bonora E, Lamb JA, Bamby G, Sykes N, Moberly T, Beyer KS et al. Mutation screening and association analysis of six candidate genes for autism on chromosome 7q.Eur J Hum Genet 13: 198–207, 2005.
Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Faner LA. Complement factor H polymorphism and age-related macular degeneration.Science 308: 421–424, 2005.
Olson NE. The microarray data analysis process: from raw data to biological significance.NeuroRx 2006.
Almudevar et al.NeuroRx 2006.
Storey JD, Tibshirani R. Statistical significance for genomewide studies.Proc Natl Acad Sci USA 100: 9440–9445, 2003.
Uhl GR, Grow RW. The burden of complex genetics in brain disorders.Arch Gen Psychiatry 61: 223–239, 2004.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uhl, G.R. Molecular genetics of addiction vulnerability. NeuroRX 3, 295–301 (2006). https://doi.org/10.1016/j.nurx.2006.05.006
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.nurx.2006.05.006